BioMarin Pharmaceutical Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $1.02B | $180.5M |
| FY2013 | — | $1.34B | $568.8M |
| FY2014 | — | $1.53B | $875.5M |
| FY2015 | — | $2.40B | $397.0M |
| FY2016 | — | $2.77B | $408.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2012 | — | $1.02B | $180.5M |
| FY2013 | — | $1.34B | $568.8M |
| FY2014 | — | $1.53B | $875.5M |
| FY2015 | — | $2.40B | $397.0M |
| FY2016 | — | $2.77B | $408.3M |